Study Shows Actos Lowers Risk of Developing Diabetes in People With Prediabetes
The diabetes drug Actos, which increases insulin sensitivity, appears to dramatically lower diabetes risk in people with prediabetes, according to a new study.
People with prediabetes who took the drug had a 72% reduction in diabetes risk, compared to patients who did not take it, researchers report.
They estimate that one case of diabetes could be prevented if 18 high-risk people were treated with the drug for a year.
The study appears in the March 24 issue of The New England Journal of Medicine.
The findings suggest that millions of people at high risk for diabetes may benefit from taking Actos, but experts urge caution.
Actos (pioglitazone) is in the same drug class as the controversial diabetes drug Avandia.
Read full post…
Recent Comments